Now, as a postdoc in Dr. Vincent Youngs lab at the University of Michigan, she studies Clostridium difficile infection, an antibiotic-associated pathogen of the GI tract, and its relationship with ...

Clostridium difficile infection is increasingly common with a high risk of recurrence despite antibiotic treatment. In cases of recurrent C. difficile infection, fecal microbiota transplant (FMT ...

From now on, US physicians and researchers will have to get approval from the FDA before they can perform a stool transplant. Researchers performing the procedure—which has emerged as an effective way ...

The use of fecal microbiota, live-jslm (RBL; REBYOTA®) in the prevention of recurrent Clostridioides difficile infection ...

In Lausanne, severe intestinal inflammation is treated with pills made from faecal bacteria. The University Hospital of ...

For patients with type 1 diabetes with moderate-to-severe gastrointestinal symptoms, fecal microbiota transplantation (FMT) is safe and improves clinical outcomes.